关注
Ajay Shukla
Ajay Shukla
在 aiimsbhopal.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
AK Shukla, R Jhaj, S Misra, SN Ahmed, M Nanda, D Chaudhary
Journal of family medicine and primary care 10 (9), 3303-3308, 2021
612021
Cost analysis of antiepileptic drugs available in India
AK Shukla, R Mehani
Int J Basic Clin Pharmacol 5 (4), 1636-40, 2016
202016
An observational multi-centric COVID-19 sequelae study among health care workers
AK Shukla, S Atal, A Banerjee, R Jhaj, S Balakrishnan, PK Chugh, ...
The Lancet Regional Health-Southeast Asia 10, 2023
192023
Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers-A Multicentric Cohort Study Assessing Effectiveness and Safety.
B Dinesh, J CS, CP Kaur, F Atiya, G Yk, H Avijit, K Sandhya, K Vp, ...
The Journal of the Association of Physicians of India 69 (6), 11-12, 2021
122021
Comparative study of tramadol and diclofenac as analgesic for postoperative pain
AK Shukla, AK Srivastav
Int J Med Res Rev 3 (11), 1311-1316, 2015
122015
Cost variation analysis of antidyslipidemic drugs
PS AK Shukla
Int J Basic Clin Pharmacol 5 (5), 1850-5, 2016
92016
Antibody-dependent enhancement of virus infection and disease: implications in COVID-19
AK Shukla, S Misra
Journal of Basic and Clinical Physiology and Pharmacology 33 (1), 13-16, 2022
82022
Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic
AK Shukla, S Misra
Journal of Basic and Clinical Physiology and Pharmacology 34 (4), 429-444, 2023
72023
An overview of post COVID sequelae
AK Shukla, S Misra
Journal of basic and clinical physiology and pharmacology 33 (6), 715-726, 2022
72022
Cost variation study of antidepressant drugs
AK Shukla, P Sharma
International Journal of Basic & Clinical Pharmacology 5 (5), 1816-1822, 2016
72016
Stimulated reporting of adverse events following immunization with COVID-19 vaccines
R Jhaj, D Chaudhary, AK Shukla, J Yadav
Vaccines 10 (12), 2133, 2022
62022
Brexanolone: Panacea for postpartum depression? Reply to:‘Intravenous brexanolone for postpartum depression: What it is, how well does it work, and will it be used?’
AK Shukla, R Jhaj, B Sadasivam
Therapeutic Advances in Psychopharmacology 11, 2045125321997293, 2021
62021
Cost analysis of antipsychotic drugs available in India
AK Shukla, A Agnihotri
Int J Basic Clin Pharmacol 6 (3), 669-74, 2017
62017
Teplizumab: type 1 diabetes mellitus preventable?
S Misra, AK Shukla
European Journal of Clinical Pharmacology 79 (5), 609-616, 2023
52023
Clinical implications of anti-idiotype antibodies in COVID-19
AK Shukla, S Misra
Journal of Basic and Clinical Physiology and Pharmacology 33 (6), 727-733, 2022
52022
Comparative study of tramadol and piroxicam as analgesic for postoperative pain in patients operated for inguinal hernia and hydrocele
AK Shukla, M Raja, AK Srivastav
Int J Basic Clin Pharmacol 5, 312-16, 2016
52016
Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers …
R Joshi, B Medhi, A Prakash, S Chandy, J Ranjalkar, HR Bright, J Basker, ...
Indian Journal of Pharmacology 54 (5), 321-328, 2022
42022
Comparative study of telmisartan and ramipril as an antihypertensive in mild to moderate hypertension
M Raja, AK Shukla, R Mehani, A Agnihotri
National Journal of Physiology, Pharmacy and Pharmacology 6 (5), 388-388, 1970
41970
Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer’s disease
AK Shukla, S Misra
Journal of Basic and Clinical Physiology and Pharmacology 35 (1-2), 25-29, 2024
32024
Health care associated infections, antimicrobial resistance and outcomes in patients admitted to intensive care unit, India: A Five-Year retrospective cohort study
S Chenchula, B Sadasivam, A Shukla, S Pathan, Saurabh saigal
Journal of Infection Prevention 24 (4), 159-165, 2023
32023
系统目前无法执行此操作,请稍后再试。
文章 1–20